Large collections of gene signatures play a pivotal role in interpreting results of omics data analysis but suffer from compositional (large overlap) and functional (redundant read-outs) redundancy, and many gene signatures rarely pop-up in statistical tests. Based on pancancer data analysis, here we define a restricted set of 962 so called informative signatures and demonstrate that they have more chances to appear highly enriched in cancer biology studies. We show that the majority of informative signatures conserve their weights for the composing genes (eigengenes) from one cancer type to another. We construct InfoSigMap, an interactive online map showing the structure of compositional and functional redundancies between informative signatures and charting the territories of biological functions accessible through transcriptomic studies. InfoSigMap can be used to visualize in one insightful picture the results of comparative omics data analyses and suggests reconsidering existing annotations of certain reference gene set groups.
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INTRODUCTION
The majority of the studies exploring gene expression data result in one or more gene signatures, i.e. list of genes sharing a common pattern of expression that can be employed to classify an independent dataset. Together with such "data-derived" signatures, "a priori knowledge-based" gene signatures are produced from the available gene ontologies or pathway databases. In recent years, data-derived and a priori-knowledge-based reference gene signatures have been widely employed to interpret the results of gene expression data analyses (e.g. differential expression, clustering). The number of available signatures is getting larger allowing users to benefit for a more exhaustive coverage of the existing biological processes. However, not all the signatures contained in these compendia are equally informative and the number of gene sets representing the same biological process is not equilibrated. Intrinsic redundancy and the presence of numerous signatures which have small chances to be selected in any analysis affects the results by heavy p-value corrections producing a higher number of false negative results. Conceptually, the aforementioned gene set redundancy can be of two types: compositional or functional (see Figure 1A ). Compositionally redundant signatures are characterized by a large intersection in terms of the composing genes. On the opposite, two signatures will be here called functionally redundant when they represent two different (sometimes, with zero overlap) transcriptional read-outs of the same biological process. The presence of multiple functionally redundant signatures affects the enrichment analysis by highly scoring multiple gene sets belonging to analogous or related biological processes hiding other potentially relevant hits. Of note, any estimation of the functional redundancy is conditioned on the context (e.g., certain cancer type) and, therefore, depends on the data corpus which defines functional (e.g., correlation-based) relations between the individual genes.
To our knowledge, few methods have been proposed to address the problem of gene signature redundancy [1] [2] [3] [4] [5] [6] . Currently, the best attempt to define a robust and not-redundant collection of signatures is represented by the MSigDB Hallmarks (H) collection 7 . H was obtained by merging and re-organizing compositionally redundant signatures and then refining the genes of the resulting signatures based on their ability to discriminate the associated phenotype. The Hallmarks collection methodology thus involves a manual curation and redefinition of signatures steps, which might create certain bias vis a vis an expert's opinion leading to the loss of certain signature properties. More importantly, H, as all the other currently proposed procedures, takes into account only compositional redundancy without exploiting the problem of the functional one.
In this paper, a new approach to prioritize and classify gene signatures is proposed. Our method is based on the concept of "an informative signature", which is capable of defining a ranking of samples independently on their labeling. Considering the simplest case of a gene signature composed of only two genes X and Y, their co-variance can define three possible scenarios of samples distribution (ranking), as reported in Figure 1B . Whereas the ranking defined by informative signatures presents a distinguishable axis (anisotropy), labels are required to define a samples ranking in the noninformative ones. As a consequence, when the dysregulation of an informative signature is tested on a two-conditions transcriptomics dataset, a significant enrichment score will be observed whenever the samples membership matches the direction of the largest variance and this is significantly greater than randomly expected (the gene set is "overdispersed"). In all other cases, a very specific distribution of sample labels is needed to obtain a significant enrichment score. Therefore, informative signatures, systematically defining robust and "objective" sample ranking in many datasets, are more valuable for data analysis.
Starting from a vast collection of signature compendia, composed of 12096 a priori-knowledge and data-derived signatures, we defined a restricted collection of 962 informative signatures, which is made available to the users for further applications. The collection was defined by exploiting a large pan-cancer TCGA collection of transcriptomic profiles (32 cancer types with totally 8991 transcriptomic profiles) and it is thus cancer biology-oriented. Of note is the fact that among the databases under investigation, a relatively small SPEED collection 8 proved to be the most informative with 55% of its signatures being highly informative. The reliability of our signature collection was then validated by comparing their performances with those of the starting complete collection in some typical data analysis scenarios. In all the considered examples, the informative gene sets were found much more frequently significant than the others, confirming the rationale behind the selection procedure here proposed.
Each signature defines a set of weights for the composing genes (which we term eigengene 9 ) in each analyzed dataset. We introduce the notion of "conserved signatures", i.e. those signatures whose eigengenes are highly correlated across different cancer types. 73% of our informative signatures resulted to be also highly conserved, pointing out that they map well some universal functional blocks of the cellular machinery. The collection of informative gene signatures was classified by computing the average correlation between the sample activity profiles of all signatures across 32 cancers types.
This metrics was used as a measure of functional redundancy in our analysis. We found that functional redundancy is an abundant phenomenon that does not result from a significant intersection size of two gene sets. Therefore the Hallmarks and the other previous works, employing only the overlap as a measure of redundancy, are capturing only a small portion of this phenomenon. In order to visually and interactively represent the structure of functional redundancies between informative gene signatures, we developed InfoSigMap (http://navicell.curie.fr/pages/maps_avcorrmodulenet.html), a user-friendly interactive Google Mapsbased tool whose nodes are constituted by our set of informative signatures and whose links represent the two types of redundancies (compositional and functional). InfoSigMap can be used as a data visualization tool to provide a quick navigation into any set of scores associated to the informative signatures (e.g., enrichment scores). The use of InfoSigMap is demonstrated in some typical data analysis scenarios showing that it is able to provide a concise and biologically meaningful holistic view on the pattern of differential regulation of various cellular functions.
RESULTS

Informative signatures represent a small fraction of the widely employed gene sets
Defined the concept of "an informative signature" (see Methods), a large pan-cancer TCGA compendium of gene expression data derived from 32 solid cancer types was employed to restrict the input collection of gene signatures (12096) to 962 (see Supplementary Table S2 ) informative for cancer data analysis and corresponding to our compendium (for the selection procedure and inputs see Methods). Of the 962 identified informative signatures the majority were data-derived (231 knowledge-based, 706 data-derived, 15 MSigDB Hallmark and 10 MSigDB C1), showing that for cancer-oriented applications data-derived signatures tend to be more informative than knowledgebased ones. In order to assess which of the input compendia was more informative, the ratio between the number of informative gene sets and the total number of contained signatures was evaluated ( Table 1 ). As shown in Table 1 , the most informative compendium resulted to be SPEED (55% of informative signatures). The reliability of this database is thus corroborated by our results, suggesting that when dealing with cancer transcriptomics data analysis it should be probably preferred to alternative ones. Overall, good performances were also obtained by CIT (28%), the MSigDB C4 (31%) and the Hallmarks (H) (30%). While the best performing knowledge-based database resulted to be ACSN, with 13% of informative signatures. The distribution of the number of tumors in which the informative signatures were found to have the ROMA L1 and L1/L2 p-values significant were then investigated. As shown in Figure 2A and Supplementary Table S2 , the majority of the informative signatures is cancer-specific (significant in only 2 cancer types), another peak is present around [15] [16] [17] [18] [19] [20] tumor types and only 8 signatures are pan-cancer significant (significant in more than 25 cancer types). Furthermore, data-driven signatures tend to be more frequently pan-cancer-wise informative than the knowledge-based ones.
Informative gene sets tend to be much more frequently significant in some typical cancer data analysis
Our hypothesis that an informative gene set has much higher chances to be enriched in a typical transcriptomic data analysis, is here tested according to the procedure detailed in the Methods section in three typical scenarios: (i) KRAS mutated vs. wild type colorectal cancer 10 ; (ii) metastatic vs.
primary colon cancer 11 and (iii) tumor vs. normal in four tissues (Lung 12 , Gastric 13 , Colon 14 , Cervix 15 ). As shown in Table 2 , in all three cases the number of informative signatures in the GSEA output was strongly enriched (average P-value 10^-79). Note that, while the selection of the informative signature was performed using an unsupervised approach, the validations presented in this section are realized using a supervised one (GSEA). Nevertheless the amount of informative signatures obtained in the output of the GSEA analysis is significantly higher than what could be expected at random.
Informative signatures perform better than the MSigDB Hallmarks in some typical cancer data analysis
Given that the only other attempt to prioritize the most reliable non-redundant signatures is represented by the MSigDB Hallmarks, its performances were compared with those of our Figure S1 , the informative signatures tend to be always associated with absolute NES higher than those of the Hallmarks. Indeed, the KS P-values are always lower than 0.05, except for the KRAS mutated vs. wild type colorectal cancer example in which the P-value is 0.098. Therefore, not only the informative signatures have higher chances to be significant in a GSEA analysis, but also in the GSEA output they tend to be among those with the highest NES score. This result indicates that our compendium is capturing the strongest sources of expression variation in all three transcriptomic datasets. As a further check, given that 15 over 50 Hallmarks signatures are also contained in our informative collection, the fraction of Hallmarks signatures present in the output of the GSEA analysis and also contained in our informative compendium is evaluated: (i) KRAS mutated vs. wild type colorectal cancer 67%; (ii) metastatic vs. primary colon cancer 67% and (iii) normal tissue vs. tumor in 4 tissues (Lung 48%, Gastric 47%, Colon 44%, Cervix 60%). Such a result shows that among the 50 signatures constituting the MSigDB Hallmarks, those that are found significant in the GSEA analysis are in the majority of the cases also informative. This last observation thus further confirms the reliability of our selection procedure taking into account that the subset of the Hallmarks that we selected tends to be enriched more frequently in the analyzed cancer-specific applications.
The majority of the informative signatures eigengenes are conserved across cancer types
To further investigate the reliability of our informative collection, we verified if the informative signatures were quantitatively reproduced across different cancer types, where the term quantitatively refers to the eigengenes (set of gene weights) resulting from the PCA decomposition. Computing the conservation score as described in the Methods section and employing a threshold of 10 -6 , 1459 over the 12096 starting signatures (12%) resulted to be conserved across-cancer. On the opposite 703 over the 962 informative signatures (73%) were found to be conserved, showing that the signatures selected with our approach have higher chances to maintain the same quantitative definition across different cancer types and thus they tend to be more robust than the starting ones. Testing then the much stringent threshold of 10 -10 , while the total number of conserved signatures substantially decreased (from 1459 to 408) the percentage of conserved signatures that were found to be also informative substantially increased (from 48% to 83%). This last result thus proves that the previously obtained results are not affected by the value of the chosen conservation score threshold and, more importantly, that the informative signatures are always among the most across-cancer conserved gene sets.
Functional redundancy of gene sets is poorly explained by their intersection size
Two gene sets with empty intersection can represent incomplete transcriptional read-outs of the same biological process (i.e., cell cycle), being thus functionally redundant. For example, when data-derived expression signatures are constructed, the number of genes whose expression is associated with the phenotype of interest is generally minimized and only the most representative are maintained in the signature. This procedure may lead to the reconstruction of two data-derived signatures associated to the same phenotype but having a poor/null intersection. This leads to a well-known problem of signature reproducibility 16 . In order to quantify the scale of this phenomenon, the two redundancy measures: functional redundancy, computed as described in the Methods section, and gene content intersection in terms of Jaccard-index (JI) are compared in Figure 2B . As expected, high JI value usually results in high functional redundancy (i.e. high average correlation between meta-samples over all cancer types). However, as shown in the figure, high functional redundancy is distributed over a large range of JI values with a surprisingly higher points density in the area corresponding to poorly overlapping gene sets. Therefore, in order to reduce the functional redundancy between gene sets, it is not sufficient to simply take into account their overlap, but also their correlation of activity needs to be considered. A first consequence of this result is that the Hallmarks collection, based on the use of the JI as a measure of redundancy, is not able to completely capture analogous signatures. To better quantify redundancy, also the meta-samples correlation need to be considered. The intrinsic limitation of such approach is that it requires the wide employment of expression data and thus its output is data-dependent.
InfoSigMap a user-friendly interactive representation of the functional redundancy structure between informative signatures for insightful gene set score visualization
Given the predefined collection of informative signatures, GSEA or alternative approaches can be employed in order to score them based on a transcriptomics dataset and a set of sample labels. The the second, instead, is part of the proliferation component, strongly linked to the cell cycle area. We considered that such unexpected configuration could be caused by the presence of gene sets, belonging to the EI category, but obtained from differentiation induction experiments or on immortalized cell lines, and thus characterized by differences in the proliferation rate. Indeed an alteration in the cell cycle process could justify the high correlation of activity (reflected in an high density of links) present between these two sets of signatures. In order to test this hypothesis, a dataset obtained from the expression profiling of human CD4+ T cell during differentiation induction was employed 19 . The informative pathways altered during the experiment (differentiated vs undifferentiated) were detected employing ROMA according to the procedure described in Methods section. As shown in Supplementary Figure 
InfoSigMap can be used to visualize the results of transcriptomics data analysis
InfoSigMap is tested to investigate the alterations affecting the transcriptome of the three aforementioned typical cancer problems: (i) KRAS mutated vs. wild type colorectal cancer; (ii) metastatic vs. primary colon cancer and (iii) tumor vs. normal tissue in lung, gastric, colon and cervix.
In all three cases, the procedure employing ROMA and described in Methods is applied resulting in the output shown in Figure 4 . Below the obtained results are discussed in detail:
(i) KRAS mutated vs. wild type colorectal cancer
The impact of KRAS mutation on CRC transcriptome is investigated with InfoSigMap ( Figure 4A ).
KRAS mutated CRC patients are known to be resistant to standard Epidermal Growth Factor
Receptor (EGFR) inhibitory treatments 20, 21 . The output of our analysis can thus give some indications concerning possible new processes to be targeted in KRAS mutated patients. The strongest effect reported in Figure 4A (bright red area) is the upregulation of a subset of the metastatic signatures.
This result fits with previous evidences that KRAS mutation is associated to metastasis in patients with CRC 22, 23 . Moreover an alteration of the metabolism is detectable from an upregulation of the mitochondria and oxidative phosphorylation area. This result fits with previous experimental evidences. Indeed KRAS mutation has already been shown to induce mitochondrial oxidative stress, inducing a phenotype consistent with the so-called Warburg effect, a metabolic alteration fundamental for cancer cell proliferation [24] [25] [26] . In CRC, KRAS mutation also causes an alteration of the transcriptional response and amino acid metabolism machineries, two fundamental processes for cancer cell proliferation and maintenance 27,28 . This effect is captured in our analysis by the upregulation of the mRNA translation/protein metabolism area on the InfoSigMap network.
(ii) Metastatic vs. primary colon cancer
The differential module activity between metastatic and primary Colon Cancer (CC) is studied ( Figure   4B ). As expected, an up-regulation of the collagen/EMT area of the network clearly appears on the map Figure 4B . Among the signatures found in this area, we can observe an upregulation of the miR-21 targets whose role in EMT is well-known 29,30 . Moreover, the network areas of mRNA and proteins metabolism and splicing resulted to be significantly upregulated. This is not surprising given that the aberration of the RNA processing machinery (stability, metabolism, splicing and polyadenylation) is known to be associated with cancer initiation and progression. In CC, beta-catenin (CTNNB1), involved in the Wnt pathway, is generally the cause of the RNA processing alterations 31-33 . This is confirmed in InfoSigMap; indeed CTNNB1 is found active as shown by the upregulation of its targets It is indeed significantly upregulated in cervical and gastric cancer and downregulated in colon and lung. The results thus suggest a different role of the immune system in these four tumors. A possible explanation for this result is that the tumors are associated to different levels of antigenicity, i.e. the extent to which tumor cells display HLA-restricted antigens that can be selectively or specifically recognized by T cells 38 . Tumors with low antigenicity hide against cytotoxic attack leading to a passive escape from anti-cancer immune defense. This hypothesis is supported by the observation that the HLA signature present in our network (GNF2_HLA_C) is concordantly downregulated in lung and colon and upregulated in cervix and gastric. Moreover, concerning lung cancer, its association with low antigenicity had already been observed 39 . The tumor antigenicity is one of the aspects that seem to determine if a patient will respond to a given immunotherapy. In this sense, a comprehensive pan-cancer classification of the immune component behavior could give indications regarding those individuals who are most likely to respond to immune-based therapies.
DISCUSSION
Data-driven and a priori-knowledge-based gene signatures are largely employed in cancer studies to score clinical samples according to distinct tumor subtypes, identify important cellular responses to stimuli, predict clinical outcomes and quantify the activation of signaling pathways. Nowadays signature collections are getting larger providing the benefit of a more complete coverage of the existing biological processes. However, the growth of these compendia is posing two main challenges due to the reliability and redundancy of the collected gene sets.
Here, we developed a new methodology for assessing the value of a gene set which is based on the notion of informative signature, i.e. a gene set able to systematically robustly rank tumor samples in many independent datasets. A restricted collection of 962 informative gene sets is suggested for transcriptomic data analysis in cancer biology. The robustness of the information content enclosed in our compendium is then proved showing that an informative gene set has much higher chances to be selected (enriched) in a typical scenario of transcriptomic data analyses, even in the ones using supervised methods, and that the eigengenes of the majority of the informative signatures tend to be conserved across cancer types. The redundancy of the informative collection is then investigated,
showing that functional redundancy is a frequent phenomenon not captured by the approaches previously proposed for gene signatures summarization. To integrate all the obtained results we 
METHODS
Definition of "an informative signature"
To explain the rationale behind the definition of informative signature, let us consider to apply Principal Component Analysis (PCA) to a gene expression data table whose columns correspond to the genes from a selected gene set and whose rows correspond to samples. If we observe that the variance explained by the first principal component computed for such a table is significantly larger than for a random set of genes of the same size then the considered gene set is called overdispersed 40, 41 . Intuitively, an overdispersed gene set has a stronger contribution to the data variance than expected by chance. Similarly, if the ratio between the variances explained by the first and second principal components computed for the aforementioned table is larger than for a random set of genes then the given gene set is called coordinated. Intuitively, the existence of a statistically significant gap between the first and the second eigenvalue of the covariance matrix corresponds to an overall increase in the pairwise correlations between the genes of the signature compared to what can be observed at random. The advantage of having a coordinated gene set is that it defines an axis of principal variance in the multi-dimensional distribution of samples and thus it robustly ranks samples independently on their labeling, as discussed in the Introduction (see Figure 1 ). In the context of cancer biology, we define informative a gene set that is simultaneously overdispersed and coordinated in more than two cancer types. Supplementary Table S1 .
Transcriptomics data input of the analysis
Signatures collection input of our analysis
A vast collection composed of both data-derived and a priori-knowledge-based signatures was considered as input for our analysis. The signature collections: Molecular Signature Database 
Procedure for the prioritization of those signatures that are informative in cancer biology
To detect which of the starting 12096 signatures, detailed above, were informative, we employed the Representation and quantification Of Module Activity (ROMA) tool, designed for the robust detection of overdispersed and coordinated modules 41 . The activity of each signature was thus evaluated in all the 32, previously described, expression datasets separately. Only those signatures having the pvalues associated to the variance explained by the first principal component (ROMA L1 score) and to the ratio between the variances explained by the first and second principal components (ROMA L1/L2 score) lower than 0.05 in at least two tumor datasets were prioritized.
Test if informative gene sets are more frequently enriched in typical cancer analysis scenarios
Our hypothesis that an informative gene set has much higher chances to be enriched in a typical transcriptomic data analysis, is tested by using Gene Set Enrichement Analysis (GSEA), a well-known and widely adopted supervised approach 42 . GSEA was applied to three typical cancer-related problems using the entire collection of 12096 starting signatures. The set of significant signatures was determined selecting those with a GSEA FDR q-value lower than 0.05. Then, the enrichment of our set of informative signatures in the output of the GSEA analysis was evaluated through a Fisher's exact test.
Comparison Informative signatures vs Hallmarks in typical cancer analysis scenarios
Given that only one other attempt to prioritize the most reliable non-redundant signatures exists and it is represented by the MSigDB Hallmarks, the procedure described in the previous section was repeated also for this database. The performances of our informative collection were then compared with those of the Hallmarks in terms of Fisher's exact test P-values. Moreover, the distributions of the absolute GSEA Normalized Enrichment Score (NES) for the two collections were studied and the significance of the difference between the two distributions was evaluated through a Kolmogorov-Smirnov (KS) test.
Evaluation of the signatures eigengenes conservation across-cancers
To further investigate the reliability of our informative collection, we verified if the informative signatures were quantitatively reproduced across different cancer types, where the term quantitatively refers to the eigengenes (set of gene weights) resulting from the PCA decomposition. For each informative signature, the pair-wise correlation between the eigengenes obtained in the 32 cancer types were computed and a conservation score was obtained as the geometric mean of the Pearson correlation p-values. We define a conserved gene set by having the conservation score lower than 10 -6 . To then evaluate how much the results of this test were affected by the threshold used to define a conserved gene set, also a much stringent threshold of 10 -10 was tested. 
Comparison between functional redundancy and intersection size of gene sets
Using InfoSigMap to have a global view of the signatures behavior
Gene sets can be tested for differential activity across different experimental conditions using a tool of choice (e.g. GSEA, ROMA). If ROMA is chosen for this test, first the activity of the informative signatures is evaluated by applying ROMA, then the differential module activity is evaluated by Student's t-test and fold-change applied to the ROMA activity scores. Finally, the fold-changes associated to a significant Student's t-test P-value (lower than 0.05) are mapped to the nodes of InfoSigMap as a color gradient, from red (up-regulation) to white (no significant change) to green (down-regulation), using the map staining approach described in 45 . The map is thus colored in the territories around each node creating a continuous colored pattern that helps a qualitative appreciation of the concordant/discordant behavior of large map regions.
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